Monsanto Co. v. Strickland

604 F. Supp. 2d 805, 2009 U.S. Dist. LEXIS 16287, 2009 WL 367721
CourtDistrict Court, D. South Carolina
DecidedFebruary 9, 2009
DocketCivil Action 4:05-3062-RBH
StatusPublished
Cited by1 cases

This text of 604 F. Supp. 2d 805 (Monsanto Co. v. Strickland) is published on Counsel Stack Legal Research, covering District Court, D. South Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Monsanto Co. v. Strickland, 604 F. Supp. 2d 805, 2009 U.S. Dist. LEXIS 16287, 2009 WL 367721 (D.S.C. 2009).

Opinion

FINDINGS OF FACT AND CONCLUSIONS OF LAW

R. BRYAN HARWELL, District Judge.

This is an action for patent infringement. Liability was established by virtue of the defendants’ failure to file objections to the Report and Recommendation issued by Magistrate Judge Rogers. This court subsequently denied by Order of December 3, 2008 the plaintiffs motion for summary judgment on the issue of damages. The parties agreed to waive a trial by jury on damages and submitted that issue to this Court.

A damages hearing was held on January 5, 2009. Present at the hearing were Jackson Barnes, Daniel C. Cox, and Jeff Masson on behalf of the plaintiff, Monsanto, and Everett J. Mercer and Robert Lee on behalf of the defendant, Mr. Strickland. The Court heard testimony by Dr. Timothy Taylor, the plaintiffs expert, as well as testimony by the defendant. The plaintiff was instructed to file any additional information regarding its request for attorney’s fees by January 9, 2009 and the defendant was ordered to file any response by January 16, 2009.

Having heard the testimony of the witnesses, considered all of the evidence, including previous findings by this Court, and the applicable law the Court makes the following Findings of Fact and Conclusions of Law as required by Rule 52 of the Federal Rules of Civil Procedure.

L INTRODUCTION AND PREVIOUS FINDINGS AND CONCLUSIONS

Prior to the January 5, 2009 damages trial, this Court adopted certain findings made by Magistrate Judge Thomas E. Rogers III on August 20, 2007. See also, Order, dated December 3, 2008 (Docket Entry # 163). Those findings included the following undisputed facts:

1. Monsanto developed a new plant biotechnology which is embodied in Roundup Ready® soybeans. This technology is protected by several United States patents including U.S. Patent No. 5,352,605 ... The claims of the '605 patent are drawn to a chimeric gene which is expressed in plant cells, comprising a promoter element, which can be a 35S promoter from Cauliflower Mosaic Virus (CaMV) and a structural sequence which is heterologous with respect to the promoter. (See '605 patent abstract; Affidavit of Dr. L. Curtis Hannah (“Hannah Aff.”) ¶ 22, Exhibit A).

2. Roundup Ready® soybeans were commercially introduced in 1996. All Roundup Ready® soybean seeds sold in the United States since 1996 were sold pursuant to a limited used license which explicitly prohibits an authorized purchaser from saving harvested seed for use as planting seed for a subsequent crop. (Affidavit of Eloy R. Corona (“Corona Aff.”), ¶ 5 attached as Exhibit B [to Plaintiffs Motion]).

3. All seed bags containing Roundup Ready® soybean seed sold by Monsanto or its seed partners since the product was first introduced in 1996 were marked with notice that the seed was patented. (Corona Aff., ¶ 6, Exhibit B). In particular, each bag stated that the seed was protected by U.S. Patent No. 5,352,605. (Id.) A color photocopy of an exemplar Hartz soybean seed bag setting forth the required statutory notice of patent protection is attached to Mr. Corona’s Affidavit. The seed bag label also warns: “A license must first be obtained from Monsanto Company before these seeds can be used in any way.” Id.

*809 4. Defendant purchased 463 units of Hartz branded Roundup Ready® soybean seed and 51 units of Delta Pine and Land branded Roundup Ready® soybean seed in May and June 2004. (Affidavit of William Harold Thompson (“Thompson Aff.”), ¶ 8 Exhibit C).

5. Defendant used soybean seed packaged in plain brown bags, i.e. saved seed, to plant his 2005 crop. (Thompson Aff., ¶ 4, Exhibit C.) Roundup Ready® soybean seed is not sold commercially in plain brown bags. (Corona Aff. ¶ 8, Exhibit B; Thompson Aff. ¶ 8, Exhibit C). Monsanto and its seed partners place brand names, trademarks, patent statements and logos on their seed bags. In addition, the Roundup Ready® logo is placed on all commercial bags of Roundup Ready® soybean seed sold in the United States. (Corona Aff., ¶8). The typical seed bag is multicolored. For example the Hartz seed bag is green and white with black labeling. (Corona Aff. ¶ 8, Exhibit B; also see Exhibit 2 attached to Corona Aff.).

6. Monsanto filed suit for patent infringement on or about October 28, 2005. Monsanto alleged that the Defendant, William L. Strickland, planted his 2005 soybean crop using saved Roundup Ready® soybean seed in contravention of Monsanto’s patent rights. (Complaint, ¶ 15).

7. On November 16, 2005, Monsanto inspected and sampled 442.2 acres as indicated by FSA records on which a soybean crop was produced by Defendant in 2005. (Affidavit of Donald D. Harlan (“Harlan Aff.”) ¶ 2, Exhibit D). The soybean samples were collected at random from each field in a pattern designed to represent all areas of the fields. (Id.). Thirty-five fields were sampled. (Id. at ¶ 5). Mr. Strickland identified each of the fields to the sampling team. (Id. at ¶ 2).

8. The samples collected from Defendants fields were shipped to Biolab Solutions where the soybean samples were analyzed for the presence of the CP4 EPSPS protein by ELISA. (Harlan Aff., ¶ 2, Exhibit D; Affidavit of Brian Ojala (“Ojala Aff.”), ¶ 4, Exhibit E). ELISA is an immunoassay methodology used to analyze for the CP4 EPSPS protein. If the sample tests positive for the CP4 EPSPS protein, the sample is Roundup Ready®. (Hannah Aff., ¶¶ 15, 16, 20, Exhibit A; Harlan Aff., ¶ 3, Exhibit D; Ojala Aff., ¶ 2, Exhibit E).

9. Approximately 35 fields, as sampled by the sampling team, totaling 442.2 acres of soybeans were sampled. (Harlan Aff., ¶ 5, Exhibit D). A total of 83 field samples and 3 soybean samples collected from Mr. Strickland’s combine were analyzed. All 86 samples tested positive by ELISA for the CP4 EPSPS protein unique to Roundup Ready® soybeans. (Hannah Aff., ¶¶ 14-16, Exhibit A; Harlan Aff., ¶ 5, Exhibit D; Ojala Aff., ¶ 4, Exhibit E).

10. A DNA technique called Polymerase Chain Reaction (PCR) confirmed that the patented construct found in Monsanto’s Roundup Ready® soybeans was also found in soybean samples collected from Defendant’s fields in 2005. Fourteen samples collected from 8 fields and 1 combine sample were tested by PCR. (Hannah Aff., ¶¶ 17-18, Exhibit A). The CaMV 35S CP4 construct protected by the '605 patent was detected in all 14 samples. (Hannah Aff., ¶ 18, Exhibit A).

11. The DNA sequence of one PCR product was examined in a third test. The DNA sequence of the Strickland sample matched the DNA sequence of Monsanto’s patented chimeric CaMV 35S CP4 construct, including the 35S CaMV promoter, a chloroplast transit peptide, and an EPSPS enzyme coding sequence. (Hannah Aff., ¶ 19, Exhibit A).

12. The soybeans obtained from William Strickland’s fields in November 2005, meet all of the elements of Claims 1, 2, 4 and 5 *810 of the '605 patent because the cells of these plants contained a chimeric gene in which the CaMV 35S promoter drives expression of a CP4 EPSPS structural sequence. Also, the CP4 EPSPS sequence is heterologous with respect to the CaMV 35S promoter. (Hannah Aff., ¶¶ 16,18, 20, 21, 24, 25, and 26, Exhibit A).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
604 F. Supp. 2d 805, 2009 U.S. Dist. LEXIS 16287, 2009 WL 367721, Counsel Stack Legal Research, https://law.counselstack.com/opinion/monsanto-co-v-strickland-scd-2009.